Compared to conventional electrochemical detection technologies LM-CECL technology is entirely new proprietary technology platform developed by Labmaster Ltd.


The superiority of LM-CECL technology allows it to overcome the performance limitations of previous generation’s tests relating to sensitivity, accuracy, easy to use and cost efficiency.

In Point of Care diagnostics traditional lateral flow immunoassay technology based tests has been commercially available for over 25 years. Their applicability have been limited to only yes/no tests preventing them to overcome the challenges of real future POC technology.

Quick introduction
view LM-CECL movie